These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25458615)

  • 1. Future target-based drug discovery for tuberculosis?
    Kana BD; Karakousis PC; Parish T; Dick T
    Tuberculosis (Edinb); 2014 Dec; 94(6):551-6. PubMed ID: 25458615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weak links: Advancing target-based drug discovery by identifying the most vulnerable targets.
    Bosch B; DeJesus MA; Schnappinger D; Rock JM
    Ann N Y Acad Sci; 2024 May; 1535(1):10-19. PubMed ID: 38595325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
    Manjunatha UH; Smith PW
    Bioorg Med Chem; 2015 Aug; 23(16):5087-97. PubMed ID: 25577708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the tuberculosis drug development pipeline.
    Evangelopoulos D; McHugh TD
    Chem Biol Drug Des; 2015 Nov; 86(5):951-60. PubMed ID: 25772393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New tuberculosis drugs on the horizon.
    Cole ST; Riccardi G
    Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target Discovery for New Antitubercular Drugs Using a Large Dataset of Growth Inhibitors from PubChem.
    Goldman RC
    Infect Disord Drug Targets; 2020; 20(3):352-366. PubMed ID: 30520384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Mycobacterium tuberculosis whole cell screening hits as potential antituberculosis agents.
    Cooper CB
    J Med Chem; 2013 Oct; 56(20):7755-60. PubMed ID: 23927683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance mechanisms and novel drug targets for tuberculosis therapy.
    Islam MM; Hameed HMA; Mugweru J; Chhotaray C; Wang C; Tan Y; Liu J; Li X; Tan S; Ojima I; Yew WW; Nuermberger E; Lamichhane G; Zhang T
    J Genet Genomics; 2017 Jan; 44(1):21-37. PubMed ID: 28117224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future for early-stage tuberculosis drug discovery.
    Zuniga ES; Early J; Parish T
    Future Microbiol; 2015; 10(2):217-29. PubMed ID: 25689534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural products against key Mycobacterium tuberculosis enzymatic targets: Emerging opportunities for drug discovery.
    Cazzaniga G; Mori M; Chiarelli LR; Gelain A; Meneghetti F; Villa S
    Eur J Med Chem; 2021 Nov; 224():113732. PubMed ID: 34399099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
    de Wet TJ; Warner DF; Mizrahi V
    Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to Combat Multi-Drug Resistance in Tuberculosis.
    Singh V; Chibale K
    Acc Chem Res; 2021 May; 54(10):2361-2376. PubMed ID: 33886255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis clinical trial update and the current anti-tuberculosis drug portfolio.
    Palomino JC; Martin A
    Curr Med Chem; 2013; 20(30):3785-96. PubMed ID: 23862617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-pathogen systems for early drug discovery against tuberculosis.
    Trofimov V; Costa-Gouveia J; Hoffmann E; Brodin P
    Curr Opin Microbiol; 2017 Oct; 39():143-151. PubMed ID: 29179041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets.
    Hudson SA; McLean KJ; Munro AW; Abell C
    Biochem Soc Trans; 2012 Jun; 40(3):573-9. PubMed ID: 22616869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon.
    Bhat ZS; Rather MA; Maqbool M; Ahmad Z
    Biomed Pharmacother; 2018 Jul; 103():1733-1747. PubMed ID: 29864964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico analyses for the discovery of tuberculosis drug targets.
    Chung BK; Dick T; Lee DY
    J Antimicrob Chemother; 2013 Dec; 68(12):2701-9. PubMed ID: 23838951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting tuberculosis: a glimpse of promising drug targets.
    Arora N; Banerjee AK
    Mini Rev Med Chem; 2012 Mar; 12(3):187-201. PubMed ID: 22356190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.